ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-34Q5777
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Phosphoinositide 3 Kinase PI3K Inhibitors Market Insights Forecast to 2028
BUY CHAPTERS

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Insights, Forecast to 2030

Code: QYRE-Auto-34Q5777
Report
December 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Gilead Sciences Inc
Novartis
TG Therapeutics Inc
Verastem Inc

Phosphoinositide 3-Kinase (PI3K) Inhibitors Market

PI3K inhibitors work by inhibiting PI3K enzymes, which helps in signaling the pathway for cellular functions such as growth control, metabolism, and translation initiation.
Market Analysis and Insights: Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market
The global Phosphoinositide 3-Kinase (PI3K) Inhibitors market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
There is extensive ongoing research on targeted therapies such as PI3K inhibitors with proven efficacy in oncology applications.The significant R&D in prevailing class of therapeutics has given rise to targeted therapies.
Report Covers:
This report presents an overview of global market for Phosphoinositide 3-Kinase (PI3K) Inhibitors market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Phosphoinositide 3-Kinase (PI3K) Inhibitors, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Phosphoinositide 3-Kinase (PI3K) Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Phosphoinositide 3-Kinase (PI3K) Inhibitors revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Phosphoinositide 3-Kinase (PI3K) Inhibitors revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Report

Report Metric Details
Report Name Phosphoinositide 3-Kinase (PI3K) Inhibitors Market
Segment by Type
Segment by Application
  • hospital
  • Research Institutes and Research Institutions
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer AG, Gilead Sciences Inc., Novartis AG, TG Therapeutics Inc., Verastem Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Phosphoinositide 3-Kinase (PI3K) Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Phosphoinositide 3-Kinase (PI3K) Inhibitors companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phosphoinositide 3-Kinase (PI3K) Inhibitors revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Phosphoinositide 3-Kinase (PI3K) Inhibitors Market report?

Ans: The main players in the Phosphoinositide 3-Kinase (PI3K) Inhibitors Market are Bayer AG, Gilead Sciences Inc., Novartis AG, TG Therapeutics Inc., Verastem Inc.

What are the Application segmentation covered in the Phosphoinositide 3-Kinase (PI3K) Inhibitors Market report?

Ans: The Applications covered in the Phosphoinositide 3-Kinase (PI3K) Inhibitors Market report are hospital, Research Institutes and Research Institutions, Clinic, Other

What are the Type segmentation covered in the Phosphoinositide 3-Kinase (PI3K) Inhibitors Market report?

Ans: The Types covered in the Phosphoinositide 3-Kinase (PI3K) Inhibitors Market report are CLL - Chronic Iymphocytic Ieukemia, FL - Follicular Iymphoma, Other Indications

Recommended Reports

Kinase Inhibitors

Small Molecule Inhibitors

Oncology Targeted Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 CLL - Chronic Iymphocytic Ieukemia
1.2.3 FL - Follicular Iymphoma
1.2.4 Other Indications
1.3 Market by Application
1.3.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 hospital
1.3.3 Research Institutes and Research Institutions
1.3.4 Clinic
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Perspective (2019-2030)
2.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Growth Trends by Region
2.2.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Size by Region (2019-2024)
2.2.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Region (2025-2030)
2.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Dynamics
2.3.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Trends
2.3.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Drivers
2.3.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Challenges
2.3.4 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Phosphoinositide 3-Kinase (PI3K) Inhibitors by Players
3.1.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Players (2019-2024)
3.1.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Players (2019-2024)
3.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Phosphoinositide 3-Kinase (PI3K) Inhibitors, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Concentration Ratio
3.4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in 2023
3.5 Global Key Players of Phosphoinositide 3-Kinase (PI3K) Inhibitors Head office and Area Served
3.6 Global Key Players of Phosphoinositide 3-Kinase (PI3K) Inhibitors, Product and Application
3.7 Global Key Players of Phosphoinositide 3-Kinase (PI3K) Inhibitors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Phosphoinositide 3-Kinase (PI3K) Inhibitors Breakdown Data by Type
4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Size by Type (2019-2024)
4.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Type (2025-2030)
5 Phosphoinositide 3-Kinase (PI3K) Inhibitors Breakdown Data by Application
5.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Size by Application (2019-2024)
5.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2019-2030)
6.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
6.2.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024)
6.2.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2025-2030)
6.2.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2019-2030)
6.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
6.3.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024)
6.3.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2025-2030)
6.3.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2030)
6.4 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
6.4.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2019-2024)
6.4.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2019-2030)
7.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
7.2.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024)
7.2.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2025-2030)
7.2.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2019-2030)
7.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
7.3.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024)
7.3.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2025-2030)
7.3.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2030)
7.4 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
7.4.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2019-2024)
7.4.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2019-2030)
8.2 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
8.2.1 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024)
8.2.2 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2025-2030)
8.2.3 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2019-2030)
8.3 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
8.3.1 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024)
8.3.2 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2025-2030)
8.3.3 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2019-2030)
9.2 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
9.2.1 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024)
9.2.2 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2025-2030)
9.2.3 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2019-2030)
9.3 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
9.3.1 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024)
9.3.2 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2025-2030)
9.3.3 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2030)
9.4 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region
9.4.1 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2019-2024)
9.4.3 Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
10.2.1 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
10.3.1 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
10.4.1 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.1.4 Bayer AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
11.1.5 Bayer AG Recent Developments
11.2 Gilead Sciences Inc.
11.2.1 Gilead Sciences Inc. Company Details
11.2.2 Gilead Sciences Inc. Business Overview
11.2.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.2.4 Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
11.2.5 Gilead Sciences Inc. Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.3.4 Novartis AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
11.3.5 Novartis AG Recent Developments
11.4 TG Therapeutics Inc.
11.4.1 TG Therapeutics Inc. Company Details
11.4.2 TG Therapeutics Inc. Business Overview
11.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.4.4 TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
11.4.5 TG Therapeutics Inc. Recent Developments
11.5 Verastem Inc.
11.5.1 Verastem Inc. Company Details
11.5.2 Verastem Inc. Business Overview
11.5.3 Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.5.4 Verastem Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
11.5.5 Verastem Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Bayer
Gilead Sciences Inc
Novartis
TG Therapeutics Inc
Verastem Inc
List of Tables
    Table 1. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of CLL - Chronic Iymphocytic Ieukemia
    Table 3. Key Players of FL - Follicular Iymphoma
    Table 4. Key Players of Other Indications
    Table 5. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Region (2019-2024)
    Table 9. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Region (2025-2030)
    Table 11. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Trends
    Table 12. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Drivers
    Table 13. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Challenges
    Table 14. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Restraints
    Table 15. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Share by Players (2019-2024)
    Table 17. Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors as of 2023)
    Table 18. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Phosphoinositide 3-Kinase (PI3K) Inhibitors, Headquarters and Area Served
    Table 21. Global Key Players of Phosphoinositide 3-Kinase (PI3K) Inhibitors, Product and Application
    Table 22. Global Key Players of Phosphoinositide 3-Kinase (PI3K) Inhibitors, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Type (2019-2024)
    Table 26. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Type (2025-2030)
    Table 28. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Share by Application (2019-2024)
    Table 30. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Share by Application (2025-2030)
    Table 32. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Bayer AG Company Details
    Table 65. Bayer AG Business Overview
    Table 66. Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product
    Table 67. Bayer AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024) & (US$ Million)
    Table 68. Bayer AG Recent Developments
    Table 69. Gilead Sciences Inc. Company Details
    Table 70. Gilead Sciences Inc. Business Overview
    Table 71. Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product
    Table 72. Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024) & (US$ Million)
    Table 73. Gilead Sciences Inc. Recent Developments
    Table 74. Novartis AG Company Details
    Table 75. Novartis AG Business Overview
    Table 76. Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product
    Table 77. Novartis AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024) & (US$ Million)
    Table 78. Novartis AG Recent Developments
    Table 79. TG Therapeutics Inc. Company Details
    Table 80. TG Therapeutics Inc. Business Overview
    Table 81. TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product
    Table 82. TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024) & (US$ Million)
    Table 83. TG Therapeutics Inc. Recent Developments
    Table 84. Verastem Inc. Company Details
    Table 85. Verastem Inc. Business Overview
    Table 86. Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product
    Table 87. Verastem Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024) & (US$ Million)
    Table 88. Verastem Inc. Recent Developments
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type: 2023 VS 2030
    Figure 3. CLL - Chronic Iymphocytic Ieukemia Features
    Figure 4. FL - Follicular Iymphoma Features
    Figure 5. Other Indications Features
    Figure 6. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application: 2023 VS 2030
    Figure 8. hospital Case Studies
    Figure 9. Research Institutes and Research Institutions Case Studies
    Figure 10. Clinic Case Studies
    Figure 11. Other Case Studies
    Figure 12. Phosphoinositide 3-Kinase (PI3K) Inhibitors Report Years Considered
    Figure 13. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Region: 2023 VS 2030
    Figure 16. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Players in 2023
    Figure 17. Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in 2023
    Figure 19. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2019-2030)
    Figure 21. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2030)
    Figure 22. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2019-2030)
    Figure 23. United States Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2019-2030)
    Figure 27. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2030)
    Figure 28. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2019-2030)
    Figure 29. Germany Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2019-2030)
    Figure 37. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2030)
    Figure 38. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2019-2030)
    Figure 40. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2030)
    Figure 41. Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Region (2019-2030)
    Figure 42. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2019-2030)
    Figure 52. Brazil Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Bayer AG Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
    Figure 59. Gilead Sciences Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
    Figure 60. Novartis AG Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
    Figure 61. TG Therapeutics Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
    Figure 62. Verastem Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Phosphoinositide 3 Kinase Inhibitor Market Research Report 2024
Global Pan PI3K Inhibitor Market Research Report 2024
Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PI3K AKT mTor Pathway Inhibitors for Breast Cancer Market Research Report 2024
Global Kinase Inhibitors Market Insights Forecast to 2030
Global Kinase Inhibitors For Cancer Treatment Market Research Report 2024
Global Tyrosine Kinase Inhibitors Market Research Report 2024
Global MEK Inhibitors Market Insights Forecast to 2030
mTOR Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cyclin Dependent Kinase CDK Inhibitors Market Research Report 2025
Global Enzyme Poly ADP Ribose Polymerase PARP Inhibitor Market Insights Forecast to 2030
Global Janus Kinase JAK Inhibitors Market Insights Forecast to 2030
Global HER2 Human Epidermal Growth Factor Receptor 2 Inhibitors Market Research Report 2024
Global Protein Kinase C Inhibitor Market Research Report 2024
Global JAK and PI3K Signaling Pathway Market Insights Forecast to 2030
Global PIK3CB Antibody Market Research Report 2024
PARP Inhibitors for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Drug based on PARP Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CDK4 6 Inhibitors Market Research Report 2024
Global Hedgehog Pathway Inhibitors Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions